Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models
Author:
Funder
National Research Foundation of Korea
Publisher
Elsevier BV
Subject
Toxicology,General Medicine,Food Science
Reference55 articles.
1. Survivin, cancer networks and pathway-directed drug discovery;Altieri;Nat. Rev. Canc.,2008
2. Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer;Araki;Breast Cancer,2018
3. HSP90 inhibitor AUY922 can reverse Fulvestrant induced feedback reaction in human breast cancer cells;Bai;Canc. Sci.,2017
4. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012
5. Multiple pesticides in mothers' hair samples and children's measurements at birth: results from the French national birth cohort (ELFE);Beranger;Int. J. Hyg Environ. Health,2020
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stimulation of estrogen receptor-alpha by hydroxyanilide fungicide, fenhexamid promotes lipid accumulation in 3 T3-L1 adipocyte;Pesticide Biochemistry and Physiology;2024-02
2. Improved procedure for square-wave voltammetric sensing of fenhexamid residues on blueberries peel surface at the anodically pretreated boron-doped diamond electrode;Analytica Chimica Acta;2023-04
3. Comparative evaluation of chemical composition, antioxidant capacity, and some contaminants in six Moroccan medicinal and aromatic plants;Biocatalysis and Agricultural Biotechnology;2023-01
4. A fungicide, fenhexamid, is involved in the migration and angiogenesis in breast cancer cells expressing estrogen receptors;Life Sciences;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3